How Allergan Continues to Make Drug Prices Insane BloombergQuintFull coverage https://www.bloombergquint.com/opinion/2018/01/09/how-allergan-continues-to-make-drug-prices-insane
Allergan: 1000 Layoffs Prove Growth Is Dead Seeking AlphaFull coverage https://seekingalpha.com/article/4135686-allergan-1000-layoffs-prove-growth-dead
Allergan to Cut Jobs Amid Loss of Exclusivity for Key Drugs Zacks.comFull coverage https://www.zacks.com/stock/news/287852/allergan-to-cut-jobs-amid-loss-of-exclusivity-for-key-drugs
Allergan cutting 1000 jobs in cost-cutting move Madison.comFull coverage http://host.madison.com/business/allergan-cutting-jobs-in-cost-cutting-move/article_8503cfe8-69a0-564d-adc5-52029012bcdf.html
Status Update: Peregrine Pharma has new CEO: South County Outreach awarded $200000 for seniors program OCRegisterFull coverage https://www.ocregister.com/2018/01/02/status-update-peregrine-pharma-has-new-ceo-south-county-outreach-awarded-200000-for-seniors-program-2/
Glaukos Announces Submission of Pre-Market Approval Application for the iStent Inject® Trabecular Micro-Bypass satPRnews (press release)Full coverage http://www.satprnews.com/2017/12/27/glaukos-announces-submission-of-pre-market-approval-application-for-the-istent-inject-trabecular-micro-bypass/
Peregrine Names CEO, to Change Name Orange County Business JournalFull coverage http://www.ocbj.com/news/2017/dec/26/peregrine-names-ceo-change-name/
Allergan: FDA Accepts NDA For Acne Drug Seysara NasdaqFull coverage http://www.nasdaq.com/article/allergan-fda-accepts-nda-for-acne-drug-seysara-20171220-01120
Positive Topline Results from Phase 3 Study of Cariprazine for the Treatment of Bipolar I Depression
Positive Topline Results from Phase 3 Study of Cariprazine for the Treatment of Bipolar I Depression MedicalResearch.com (blog)Full coverage https://medicalresearch.com/mental-health-research/bipolar-disorder/positive-topline-results-from-phase-3-study-of-cariprazine-for-the-treatment-of-bipolar-i-depression/39025/
Clinical Research 